"DNA Repair Enzymes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes that are involved in the reconstruction of a continuous two-stranded DNA molecule without mismatch from a molecule, which contained damaged regions.
| Descriptor ID |
D045643
|
| MeSH Number(s) |
D08.811.074
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "DNA Repair Enzymes".
Below are MeSH descriptors whose meaning is more specific than "DNA Repair Enzymes".
This graph shows the total number of publications written about "DNA Repair Enzymes" by people in this website by year, and whether "DNA Repair Enzymes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1995 | 0 | 2 | 2 |
| 1997 | 2 | 3 | 5 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 2 | 2 | 4 |
| 2004 | 3 | 2 | 5 |
| 2005 | 1 | 2 | 3 |
| 2006 | 1 | 5 | 6 |
| 2007 | 4 | 6 | 10 |
| 2008 | 8 | 3 | 11 |
| 2009 | 3 | 6 | 9 |
| 2010 | 4 | 6 | 10 |
| 2011 | 3 | 7 | 10 |
| 2012 | 5 | 2 | 7 |
| 2013 | 3 | 5 | 8 |
| 2014 | 7 | 3 | 10 |
| 2015 | 6 | 1 | 7 |
| 2016 | 3 | 2 | 5 |
| 2017 | 6 | 2 | 8 |
| 2018 | 1 | 4 | 5 |
| 2019 | 5 | 1 | 6 |
| 2020 | 1 | 0 | 1 |
| 2021 | 4 | 3 | 7 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "DNA Repair Enzymes" by people in Profiles.
-
Temozolomide use in elderly patients with MGMT promoter unmethylated glioblastoma: Is it finally time to dismount a dead horse? Neuro Oncol. 2024 Oct 03; 26(10):1876-1877.
-
Somatostatin Receptor Subtype-2 Targeting System for Specific Delivery of Temozolomide. J Med Chem. 2024 02 22; 67(4):2425-2437.
-
Whole genome sequencing followed by functional analysis of genomic deletion encompassing ERCC8 and NDUFAF2 genes in a non-consanguineous Indian family reveals dysfunctional mitochondrial bioenergetics leading to infant mortality. Mitochondrion. 2024 Mar; 75:101844.
-
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results. Acta Neuropathol Commun. 2023 11 02; 11(1):175.
-
MRNIP condensates promote DNA double-strand break sensing and end resection. Nat Commun. 2022 05 12; 13(1):2638.
-
Assessing kinetics and recruitment of DNA repair factors using high content screens. Cell Rep. 2021 12 28; 37(13):110176.
-
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study. Neuro Oncol. 2021 10 01; 23(10):1736-1749.
-
PRPF19 regulates p53-dependent cellular senescence by modulating alternative splicing of MDM4 mRNA. J Biol Chem. 2021 07; 297(1):100882.
-
X-ray scattering reveals disordered linkers and dynamic interfaces in complexes and mechanisms for DNA double-strand break repair impacting cell and cancer biology. Protein Sci. 2021 09; 30(9):1735-1756.
-
PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma. Neuro Oncol. 2021 06 01; 23(6):920-931.